This paper is only available as a PDF. To read, Please Download here.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Biological Psychiatry
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Effect of electroconvulsive treatment on cerebral opioid receptors in the rat: Changes in the delta and mu receptors.Naunyn-Schmiedeberg Arch Pharmacol. 1984; 328: 87-89
- Predictors for improvement after electroconvulsive therapy in parkinsonian patients with “on-off” symptoms.J Neurol Transm. 1981; 52: 199-211
- Naloxone may be beneficial in the treatment of tardive dyskinesia.Clin Neuropharmacol. 1984; 7: 265-267
- Effects of electroconvulsive therapy on mood, parkinsonism and tardive dyskinesia in a depressed patient: ECT and dopamine systems.Biol Psychiatry. 1983; 18: 865-873
- The role of the substantia nigra in motility of the rat. Muscular rigidity, body asymmetry and catalepsy after injection of morphine into the nigra.Neuropharmacology. 1983; 22: 1039-1048
- Dissociation of motor response from mood and cognition in a parkinsonian patient treated with ECT.Biol Psychiatry. 1985; 20: 566-569
© 1986 Published by Elsevier Inc.